Alectinib 150mg capsules
NHS hospitals in England used £32,918,063 of indicative cost of Alectinib 150mg capsules in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 9.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Alectinib 150mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Alectinib 150mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Royal Marsden Nhs Foundation Trust | £1,828,952 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,452,990 |
| The Christie Nhs Foundation Trust | £1,250,452 |
| Barts Health Nhs Trust | £859,214 |
| Univ Hpls Bristol Nhs Foundation Trust | £823,631 |
| Nottingham University Hospitals Trust | £808,355 |
| Barkinghavering & Redbridge Hpls Trst | £759,832 |
| Sheffield Teaching Hospitals Nhs Trust | £754,980 |
| The Clatterbridge Cancer Centre Nhs Ft | £734,672 |
| Royal Free London Nhs Foundation Trust | £718,992 |
The primary-care picture
Alectinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Alectinib medicine page.